Companies

Cabaletta Bio, Inc. (CABA) SEC filings

CIK 0001759138 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Net income (USD)-53.0 M-46.3 M
Diluted EPS (USD/shares)-2.1-1.65-1.81

Latest filings

FiledFormDescriptionPeriod
2026-09-148-K8-K items 8.012026-09-14
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.02,9.012026-08-13
2026-08-12SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-12SCHEDULE 13GSCHEDULE 13G
2026-07-31SCHEDULE 13GSCHEDULE 13G
2026-07-27SCHEDULE 13GSCHEDULE 13G
2026-07-23SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-118-K8-K items 5.03,5.07,9.012026-06-09
2026-06-10442026-06-09
2026-06-10442026-06-09
2026-06-10442026-06-09
2026-06-10442026-06-09
2026-06-10442026-06-09
2026-06-05SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-04SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-038-K8-K items 7.01,8.01,9.012026-06-03
2026-06-01DEFA14ADEFA14A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-1410-Q10-Q2026-03-31
2026-05-148-K8-K items 2.02,9.012026-05-14
2026-05-148-K8-K items 7.01,8.01,9.012026-05-14

Forms on file (last 1,000): 4 120, 8-K 92, SC 13G/A 39, SCHEDULE 13G/A 26, SC 13G 22, 10-Q 21, 3 17, S-8 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=CABA (0.002 USD), /gw/filings/filings?ticker=CABA&form=8-K, /gw/filings/facts?ticker=CABA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange